This image is not available for purchase in your country.

Sativex multiple sclerosis drug

Sativex multiple sclerosis drug

C011/0054

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

MARK THOMAS / SCIENCE PHOTO LIBRARY MARK THOMAS / SCIENCE PHOTO LIBRARY

Caption

Sativex multiple sclerosis drug. Pharmacist holding a box containing Sativex. This cannabinoid oromucosal mouth spray was developed by GW Pharmaceuticals for multiple sclerosis patients. It is used to alleviate neuropathic pain, spasticity, overactive bladder, and other symptoms. It is also being trialled as a pain control drug for cancer patients.

Release details

Model release not required. Property release not available.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}